| abstract |
Melanin-concentrating hormone (MCH) receptor antagonists are disclosed having utility for the treatment of MCH receptor-based disorders such as obesity. The compounds of this invention have the following structure: n n nincluding pharmaceutically acceptable salts, esters, solvates, stereoisomers, and prodrugs thereof, wherein m, n, Q 1 , Q 2 , R 1 , R 2 , R 3 , R 4 , R 7 and X are as defined herein. Also disclosed are compositions containing a compound of this invention, as well as methods relating to the use thereof. |